Joey knows I've said this before, and I hate to be a downer here, but I really doubt that Ampligen will ever be approved, XMRV or no XMRV. They've been trying for 23-25 years to get the drug approved for a variety of conditions, to no avail.
Part of this may be due to what Joey said, that 'they don't really know how or why it works' (when it does), but keep in mind it was rejected for approval by the FDA just two years ago (after a 5 year process).
But for me, the main problem seems to be the poor management of the company...the half-truths, the outright lies (suggesting imminent approval in June 2009) to get the stock price up, and then the resulting crash in December 2009 when it was rejected. Others have blamed conspiracy theories, but the fact remains that management was caught in a series of lies/half-truths to investors during that period.
In June of '09 the stock price was at something like $4.60. Today it's at 27 cents.
Perhaps if they're able to bring in new management, the company can survive. But it just doesn't look good IMHO, especially considering it's 25 year history.
sorry...just my two cents.